• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


1.6000 USD 0.00000.00%

As of 20:10:00 ET on 07/18/2014.

Snapshot for Biotage AB (BITGF)

Open: - Day's Range: - Volume: 100
Previous Close: 1.6000 52wk Range: 1.5000 - 1.7100 1-Yr Rtn: -

Stock Chart for BITGF

No chart data available.
  • BITGF:US 1.6000
  • 1D
  • 1M
  • 1Y
Interactive BITGF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BITGF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 18.4511
Relative P/E vs. SPX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) 0.5950
Est. PEG Ratio -
Market Cap (M USD) 103.54
Shares Outstanding (M) 64.71
30 Day Average Volume 3
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 5.71%
Cash Dividend (SEK) 0.6000
Dividend Ex-Date 04/29/2014
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BITGF

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for BITGF

Biotage AB focuses on life sciences research. The Company provides technologies and solutions in the areas of genetic analysis and medicinal chemistry. Biotage's customers include pharmaceutical companies, biotech companies, and academic institutes. The Company has offices in several European countries, the United States, and Japan.

Torben JorgensenPresident/CEOErika Soderberg JohnsonChief Financial Officer
Anthony ReesCSOLars BackmanVP:Corp Development
More Company Profile & Key Executives for BITGF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil